- This event has passed.
Tema: Doença de Erdheim-Chester (ECD): Uma perspectiva nefrológica
[31Thu, 29 Jan 2026 13:00:00 +000000bAmerica/Chicago_America/Chicago000America/Chicago13100_2026-01-29T13:00:00+00:00pmquinta-feiraAmerica/Chicago129pmThu, 29 Jan 2026 13:00:00 +0000_2026Z31002026100]29pm31America/Chicago050031012026000000312026America/ChicagopmThu, 29 Jan 2026 13:00:00 +0000janeiro2026Thu, 29 Jan 2026 13:00:00 +000001pm31[tribe_events_calendar_options]dateTimeSeparator13h[tribe_events_calendar_options]timeRangeSeparator[31Thu, 29 Jan 2026 14:00:00 +000000bAmerica/Chicago_America/Chicago000America/Chicago13100_2026-01-29T14:00:00+00:00pmquinta-feiraAmerica/Chicago129pmThu, 29 Jan 2026 14:00:00 +0000_2026Z31002026100]29pm31America/Chicago050031022026000000312026America/ChicagopmThu, 29 Jan 2026 14:00:00 +0000janeiro2026Thu, 29 Jan 2026 14:00:00 +000001pm31[tribe_events_calendar_options]dateTimeSeparator2:00 PM CST
Speaker: Mo Atta, MD, MPH
Johns Hopkins Hospital
Department of Nephrology
Data: 29 de janeiro de 2026
Hora: 13h CST
Dr. Mohamed G. Atta is a Professor of Medicine at Johns Hopkins University where he’s a practicing Nephrologist. He trained in nephrology at the Urology and Nephrology Center at Mansoura University and at Johns Hopkins. Dr. Atta also holds a Master of Public Health degree from Johns Hopkins and is a member of multiple professional organizations, including the American Society of Nephrology. He has been the principal investigator on several studies, serves as a peer reviewer for numerous medical journals, and has authored many articles across a range of scientific publications.
